Trial NCT02663908

View at ClinicalTrials.gov 
Org. Study IDs: 000108

Last trial update was posted on 2022-06-29

MeSH Interventions

Leuprolide

MeSH Conditions

Cardiovascular Diseases Prostatic Neoplasms

Other Conditions

Prostate Cancer

Stopping Reasons

Recruitment rate; a lower than anticipated observed cardiovascular event rate. The Sponsor decision to stop the trial was not based on any safety concerns or any knowledge of the results, or influenced by issues imposed by the COVID-19 pandemic.

Limitations And Caveats

The trial was terminated prematurely due to a slower than anticipated recruitment rate and a lower than anticipated observed CV event rate. Approximately 900 patients were planned to be included, however, at the time of stopping screening and recruitment 216 patients had completed the trial, 292 were ongoing, and 37 were withdrawn. The Sponsor decision to stop the trial was not based on any safety concerns, any knowledge of the results, or influenced by issues imposed by the COVID-19 pandemic.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID